Skip to Content

V 50 (Venclexta 50 mg)

Generic Name: venetoclax

Pill with imprint V 50 is Beige, Capsule-shape and has been identified as Venclexta 50 mg. It is supplied by AbbVie Inc..

Venclexta is used in the treatment of acute myeloid leukemia; chronic lymphocytic leukemia and belongs to the drug class miscellaneous antineoplastics. Venclexta 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for V 50

Venclexta 50 mg V 50

Venclexta

Generic Name
venetoclax
Imprint
V 50
Strength
50 mg
Color
Beige
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Miscellaneous antineoplastics
CSA Schedule
Not a controlled drug
Labeler / Supplier
AbbVie Inc.
National Drug Code (NDC)
00074-0566
Inactive Ingredients
copovidone, silicon dioxide, polysorbate 80, sodium stearyl fumarate, calcium phosphate dibasic anhydrous, ferric oxide red, ferrosoferric oxide, ferric oxide yellow, polyvinyl alcohol, polyethylene glycol, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "V 50"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.